Literature DB >> 21865694

Abnormalities of glycogenes in tonsillar lymphocytes in IgA nephropathy.

Tatsuyuki Inoue1, Hitoshi Sugiyama, Masashi Kitagawa, Keiichi Takiue, Hiroshi Morinaga, Yoko Kikumoto, Yohei Maeshima, Kunihiro Fukushima, Kazunori Nishizaki, Hirofumi Akagi, Yoshiyuki Hiki, Hirofumi Makino.   

Abstract

Glycosylation, which represents the most complex post-translational modification, plays a pivotal role during protein maturation, and is orchestrated by numerous glycosyltransferases. Aberrant O-glycosylation of serum and tonsillar IgA1 is presumed to be one of the pathogeneses of IgA nephropathy (IgAN). However, the synthesis of underglycosylated IgA1 in tonsils has not yet been characterized. This study investigated tonsillar B lymphocytes of IgAN using tonsils from patients with chronic tonsillitis and sleep apnea syndrome. Gene expression of β1,3-galactosyltransferase (β3GalT), Cosmc, UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyl-transferase 2, were significantly down regulated in tonsillar CD19-positive B lymphocytes from IgAN patients compared to control as determined by real-time RT-PCR. In contrast, the level of sialyltransferase was not significantly different among the three groups. Tonsillar B cell β3GalT gene expression significantly correlated with estimated GFR and negatively correlated with proteinuria and glomerular or interstitial injury score. Double immunofluorescent staining showed that some IgA-positive cells in the intrafollicular area were also positive for β3GalT staining. Western blotting showed the protein expression of β3GalT in the tonsils to significantly decrease in IgAN in comparison to the controls. These data suggest the downregulation of β3GalT in tonsillar B lymphocytes to be closely associated with the clinical characteristics of IgAN.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865694     DOI: 10.1159/000324610

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  6 in total

1.  Promoters of Human Cosmc and T-synthase Genes Are Similar in Structure, Yet Different in Epigenetic Regulation.

Authors:  Junwei Zeng; Rongjuan Mi; Yingchun Wang; Yujing Li; Li Lin; Bing Yao; Lina Song; Irma van Die; Arlene B Chapman; Richard D Cummings; Peng Jin; Tongzhong Ju
Journal:  J Biol Chem       Date:  2015-06-10       Impact factor: 5.157

2.  Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen.

Authors:  Rongjuan Mi; Lina Song; Yingchun Wang; Xiaokun Ding; Junwei Zeng; Sylvain Lehoux; Rajindra P Aryal; Jianmei Wang; Vanja K Crew; Irma van Die; Arlene B Chapman; Richard D Cummings; Tongzhong Ju
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

3.  Mycophenolic acid reverses IgA1 aberrant glycosylation through up-regulating Cosmc expression in IgA nephropathy.

Authors:  Linshen Xie; Chunyu Tan; Junming Fan; Ping Fu; Yi Tang; Ye Tao; Wei Qin
Journal:  Int Urol Nephrol       Date:  2012-11-08       Impact factor: 2.370

4.  Comparative Analysis of Glycogene Expression in Different Mouse Tissues Using RNA-Seq Data.

Authors:  Ahmad Firoz; Adeel Malik; Sanjay Kumar Singh; Vivekanand Jha; Amjad Ali
Journal:  Int J Genomics       Date:  2014-07-09       Impact factor: 2.326

5.  Novel urinary glycan profiling by lectin array serves as the biomarkers for predicting renal prognosis in patients with IgA nephropathy.

Authors:  Chieko Kawakita; Koki Mise; Yasuhiro Onishi; Hitoshi Sugiyama; Michihiro Yoshida; Masao Yamada; Jun Wada
Journal:  Sci Rep       Date:  2021-02-09       Impact factor: 4.379

Review 6.  Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.

Authors:  Jia-Wei He; Xu-Jie Zhou; Ji-Cheng Lv; Hong Zhang
Journal:  Theranostics       Date:  2020-09-15       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.